Hyppää sisältöön
    • Suomeksi
    • In English
Trepo
  • Suomeksi
  • In English
  • Kirjaudu
Näytä viite 
  •   Etusivu
  • Trepo
  • TUNICRIS-julkaisut
  • Näytä viite
  •   Etusivu
  • Trepo
  • TUNICRIS-julkaisut
  • Näytä viite
JavaScript is disabled for your browser. Some features of this site may not work without it.

European Glaucoma Society research priorities for glaucoma care

Azuara-Blanco, Augusto; McCorry, Noleen; Tatham, Andrew J.; Georgoulas, Stelios; Founti, Panayiota; Schweitzer, Cedric; Meier-Gibbons, Frances; Denis, Philippe; Tuulonen, Anja; Johannesson, Gauti; De La Casa, José María Martínez; Prokosch, Verena; Giannoulis, Dimitrios A.; Abegão Pinto, Luis; Garway-Heath, David; Topouzis, Fotis (2023-11-03)

 
Avaa tiedosto
bjo-2023-323648.full-1.pdf (1001.Kt)
Lataukset: 



Azuara-Blanco, Augusto
McCorry, Noleen
Tatham, Andrew J.
Georgoulas, Stelios
Founti, Panayiota
Schweitzer, Cedric
Meier-Gibbons, Frances
Denis, Philippe
Tuulonen, Anja
Johannesson, Gauti
De La Casa, José María Martínez
Prokosch, Verena
Giannoulis, Dimitrios A.
Abegão Pinto, Luis
Garway-Heath, David
Topouzis, Fotis
03.11.2023

BRITISH JOURNAL OF OPHTHALMOLOGY
doi:10.1136/bjo-2023-323648
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi:tuni-202401091281

Kuvaus

Peer reviewed
Tiivistelmä
<p>Background/Aims: The goal of health research is to improve patients care and outcomes. Thus, it is essential that research addresses questions that are important to patients and clinicians. The aim of this study was to develop a list of priorities for glaucoma research involving stakeholders from different countries in Europe. Methods: We used a three-phase method, including a two-round electronic Delphi survey and a workshop. The clinician and patient electronic surveys were conducted in parallel and independently. For phase I, the survey was distributed to patients from 27 European countries in 6 different languages, and to European Glaucoma Society members, ophthalmologists with expertise in glaucoma care, asking to name up to five research priorities. During phase II, participants were asked to rank the questions identified in phase I using a Likert scale. Phase III was a 1 day workshop with patients and clinicians. The purpose was to make decisions about the 10 most important research priorities using the top 20 priorities identified by patients and clinicians. Results: In phase I, 308 patients and 150 clinicians were involved. In phase II, the highest-ranking priority for both patients and clinicians was € treatments to restore vision'. In phase III, eight patients and four clinicians were involved. The top three priorities were € treatments to stop sight loss', € treatments to restore vision' and € improved detection of worsening glaucoma'. Conclusion: We have developed a list of priorities for glaucoma research involving clinicians and patients from different European countries that will help guide research efforts and investment.</p>
Kokoelmat
  • TUNICRIS-julkaisut [20210]
Kalevantie 5
PL 617
33014 Tampereen yliopisto
oa[@]tuni.fi | Tietosuoja | Saavutettavuusseloste
 

 

Selaa kokoelmaa

TekijätNimekkeetTiedekunta (2019 -)Tiedekunta (- 2018)Tutkinto-ohjelmat ja opintosuunnatAvainsanatJulkaisuajatKokoelmat

Omat tiedot

Kirjaudu sisäänRekisteröidy
Kalevantie 5
PL 617
33014 Tampereen yliopisto
oa[@]tuni.fi | Tietosuoja | Saavutettavuusseloste